摘要
目的:建立超高效液相色谱-三重四级杆质谱联用仪(UPLC-MS/MS)法测定参芎葡萄糖注射液中阿拉伯糖、果糖、甘露糖、葡萄糖的含量测定方法,为科学评价参芎葡萄糖注射液的质量提供依据,为保障临床安全用药奠定基础。方法:采用国产GDX-403固相萃取柱净化,Waters ACQUITY UPLC BEH Xbridge Amide色谱柱(2.1 mm×100 mm,1.7μm),柱温35℃进行分析;[(0.1%氨水-乙腈)-(0.1%氨水-水)](85∶15)为流动相进行分离,流速0.3 mL·min-1,以超高效液相色谱-三重四级杆质谱联用仪(UPLC-MS/MS)测定参芎葡萄糖注射液中阿拉伯糖、甘露糖、果糖和葡萄糖含量。结果:建立了参芎葡萄糖注射液中阿拉伯糖、果糖、甘露糖、葡萄糖的含量测定方法,所测定的样品中和混合对照品中阿拉伯糖、果糖、甘露糖、葡萄糖相应的浓度范围与峰面积呈良好的线性关系,重复性、精密度良好,加样回收率分别为98.43%,102.13%,100.72%,101.75%,其RSD分别为2.4%和1.3%,3.1%,2.7%。5个批次参芎葡萄糖注射液中阿拉伯糖和甘露糖含量稳定。结论:该操作方法简便,专属性强,与总糖的含量测定相比更加科学稳定,可用于参芎葡萄糖注射液的质量控制。
Objective: To establish a method for determining arabinose,mannose,fructopyranose and amylaceum in Shenxiong glucose injection by UPLC-MS /MS,so as to provide the basis for the scientific evaluation of the quality of Shenxiong glucose injection,and lay a foundation for the safe use of drugs in clinic. Method: Domestic GDX-403 solid-phase extraction column was used to purify Waters ACQUITY UPLC BEH Xbridge Amide column ( 2. 1 mm × 100 mm,1. 7 μm) at the column temperature of 35 ℃,and the mobile phase was 0. 1% ammonia,0. 1% acetonitrile-0. 1% ammonia water and water 85 ∶ 15. The contents of arabinose,mannose, fructose and glucose in Shenxiong glucose injection were determined by UPLC-MS /MS with a flow rate of 0. 3 mL·min - 1 . Result: A method was established to determine arabinose,mannose, fructopyranose and amylaceum in Shenxiong glucose injection. The concentration range of arabinose,mannose,fructopyranose and amylaceum showed a good linear relationship with the peak area,with a good repeatability and precision. Recoveries were 98. 43%,102. 13%,100. 72%,101. 75%,and RSD were 2. 4%,1. 3%,3. 1%,2. 7%. Arabinose and mannose content were stable in five batches of Shenxiong glucose injection. Conclusion: The method is simple and specific. Compared with the determination of total sugar,the method is more scientific and stable,and can be used for the quality control of Shenxiong glucose injection.
作者
罗君
赵琳珺
朱迪
包江平
谭家华
黄健
LUO Jun;ZHAO Lin-jun;ZHU Di;BAO Jiang-ping;TAN Jia-hua;HUANG Jian(The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine,Guiyang 550001,China;Guiyang Wudang District Xintian Community Health Service,Guiyang 550008,China)
出处
《中国实验方剂学杂志》
CAS
CSCD
北大核心
2019年第4期201-205,共5页
Chinese Journal of Experimental Traditional Medical Formulae
基金
国家中医药管理局中药特色技术传承人才项目(国中医药办
人教函[2018]204号)
苗族医学研究协同创新中心项目(黔教合协同创新字[2015]05)
贵州省科技支撑计划项目(黔科合支撑[2018]2772)
贵州省科技厅贵阳中医学院第一附属医院联合基金项目(黔科合LH字[2015]7801
黔科合LH字[2017]7147号)
贵州省中医药管理局项目(QZYY2016-099
QZYY2017-89)
贵阳中医学院院内项目(贵中医科院内[2016]55号)